New Approaches to Shifting the Migraine Treatment Paradigm

New and Emerging Therapies For Migraine

The standards of migraine therapy do have limitations. For some, it is adverse events or a lack of significant improvement. For others, it is medication overuse or inability to tolerate a delivery method or regimen. Advancements in headache therapies over the past decade have aimed not only to improve efficacy but also delivery and tolerability to ultimately improve patient satisfaction. These new approaches open options for clinicians treating patients with particularly refractory and difficult migraines. Emerging therapies include CGRP-receptor antagonists, CGRP antibodies, a 5-HT1F receptor agonist, and new deliveries for proven treatments in intranasal form and non-invasive neuromodulation.

Front. Pain Res., 06 September 2022
Sec. Headache
https://doi.org/10.3389/fpain.2022.873179